Fund profile · Compiled from public sources

VC23 Investors

Avon, Connecticut, United States · Seed → Series A

Their stated focus (public profile)

VC23 Ventures focuses on Life Science and BioTools companies, believing they scale faster, reach revenue earlier, and require less capital before exit compared to therapeutics. The fund uses proprietary analytics and AI-enhanced diligence to evaluate scientific, financial, and market data. It also invests across all life science sectors, with a view that the convergence of compute, AI, and biology is driving unprecedented innovation in drug discovery, synthetic biology, and precision diagnostics.

Stages: Seed → Series A

Sectors: Life sciences, Biotools, Proteomics, Deep tech

Website: vc23investors.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →